[1] CHOI J B, KANG K, SONG M K, et al.Pain Characteristics after Total Laparoscopic Hysterectomy[J]. Int J Med Sci,2016,13(8):562-568. [2] QI M, XIAO W, YANG S, et al.Pre-incisional Preventive Precise Multimodal Analgesia May Enhance the Rehabilitation Process of Acute Postoperative Pain Following Total Laparoscopic Hysterectomy: A Randomized Controlled Trial[J]. Pain physician,2023,26(3):E123-E131. [3] ZHENG K, CHEN B, SUN J.Nalbuphine May Be Superior to Sufentanil in Relieving Postcesarean Uterine Contraction Pain in Multiparas: A Retrospective Cohort Study[J]. Drug Des Devel Ther,2023,17:1405-1415. [4] ERGIN A, AYDIN M, ÇIYILTEPE H, et al.Effectiveness of local anesthetic application methods in postoperative pain control in laparoscopic cholecystectomies; a randomised controlled trial[J]. International journal of surgery (London, England),2021,95:106134. [5] 马燕,李仲然,马开喜,等.右美托咪定复合罗哌卡因腹横肌平面阻滞对老年患者结直肠癌根治术后早期恢复质量的影响[J].临床麻醉学杂志, 2020,36(2):148-151. [6] 张鹤晨,张静,蔚冬冬,等.罗哌卡因复合布托啡诺腹横肌平面阻滞对妇科腹腔镜手术患者术后镇痛及早期康复的影响[J].临床麻醉学杂志,2020,36(2):156-159. [7] KALIKA P, XUE R, ZHENG J, et al.Efficacy of Nalbuphine as an Adjuvant to Ropivacaine in Ultrasound-guided Supraclavicular Brachial Block: A Prospective Randomized Controlled Study[J]. Clin J Pain,2020,36(4):267-272. [8] HUANG F, QIAN H, GAO F, et al.Effect of Ultrasound-Guided Fascia Iliac Compartment Block with Nalbuphine and Ropivacaine on Preoperative Pain in Older Patients with Hip Fractures: A Multicenter, Triple-Blinded, Randomized, Controlled Trial[J]. Pain Ther,2022,11(3):923-935. [9] GLARE P, AUBREY K R, MYLES P S.Transition from acute to chronic pain after surgery[J]. Lancet,2019,393(10180):1537-46. [10] TRAN D Q, BRAVO D, LEURCHARUSMEE P, et al.Transversus Abdominis Plane Block: A Narrative Review[J]. Anesthesiology,2019,131(5):1166-1190. [11] 黄孝慈,陈齐,盛奎,等.超声引导右侧星状神经节阻滞对腹腔镜胆囊切除术患者术后内脏痛及恶心呕吐的影响[J].天津医药,2023,51(2):186-190. [12] STEIN C, LANG L J.Peripheral mechanisms of opioid analgesia[J]. Curr Opin Pharmacol,2009,9(1):3-8. [13] SEHGAL N, SMITH H S, MANCHIKANTI L.Peripherally acting opioids and clinical implications for pain control[J]. Pain Physician,2011,14(3):249-258. [14] CANDY B, JONES L, VICKERSTAFF V, et al. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care[J]. Cochrane Database Syst Rev,2022,9(9):Cd006332. [15] HIROTA K, OKAWA H, APPADU B L, et al.Interaction of local anaesthetics with recombinant mu, kappa, and delta-opioid receptors expressed in Chinese hamster ovary cells[J]. Br J Anaesth,2000,85(5):740-746. [16] ABDELHAMID B M, OMAR H.Nalbuphine as an adjuvant to 0.25% levobupivacaine in ultrasound-guided supraclavicular block provided prolonged sensory block and similar motor block durations (RCT)[J]. J Anesth,2018,32(4):551-557. [17] ZENG R, DONG S, WEI Y.Influences of different doses of nalbuphine combined with propofol on the anesthetic effects, hemodynamics, inflammation and immunity of patients undergoing hysteroscopic surgery[J].Panminerva Med,2023,65(2):270-271. [18] TANG L, YE C, WANG N, et al.The median effective doses of propofol combined with two different doses of nalbuphine for adult patients during painless gastroscopy[J]. Front Pharmacol,2022,13:1014486. |